Review




Structured Review

Proteintech proteins
Proteins, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 415 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pm41793872-60-4-7
Average 96 stars, based on 415 article reviews
proteins - by Bioz Stars, 2026-10
96/100 stars

Images

Related Articles

other:

Article Title: Machine Learning and Experimental Validation of m6A RNA Methylation Related Signatures for Risk Prediction, Diagnostic Biomarkers, and Immune Subtypes in Chronic Kidney Disease
Article Snippet: The primary antibodies used in the study included: METTL3 (Proteintech, 15073-1-AP), CBLL1 (Proteintech, 21179-1-AP), ELAVL1 (Proteintech, 11910-1-AP), YTHDF1 (Proteintech, 17479-1-AP), RBM15B (Proteintech, 22249-1-AP).

Article Title: N6-methyladenosine (m 6 A) modification of TXNIP in 3′UTR instigates abdominal aorta aneurysm in mice
Article Snippet: anti-YTHDF1 , Proteintech , Cat17479-1-AP.

Cell-Signaling:

Article Title: p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.
Article Snippet: TP53 is a well-documented tumor suppressor gene frequently mutated in malignancies.. It has been demonstrated that the gain-offunction (GOF) mutation of p53 promotes the development and progression of cancers; however, its extrinsic oncogenic mechanisms are still poorly understood.. Herein, we found that the oncogenic effect of mutant p53 in vivo is dependent on the tumor immune microenvironment.

Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.

Incubation:

Article Title: N6-methyladenosine (m 6 A) modification of TXNIP in 3′UTR instigates abdominal aorta aneurysm in mice
Article Snippet: .. Dynabeads Protein A (Thermo Fischer Scientific, 100-02D) and Protein G (Thermo Fischer Scientific, 100-04D) were incubated with 2 μg of YTHDF1 antibody (Proteintech, 17479-1-AP) at 4 °C for 2 h with gentle rotation. ..

Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.

Gentle:

Article Title: N6-methyladenosine (m 6 A) modification of TXNIP in 3′UTR instigates abdominal aorta aneurysm in mice
Article Snippet: .. Dynabeads Protein A (Thermo Fischer Scientific, 100-02D) and Protein G (Thermo Fischer Scientific, 100-04D) were incubated with 2 μg of YTHDF1 antibody (Proteintech, 17479-1-AP) at 4 °C for 2 h with gentle rotation. ..

Immunostaining:

Article Title: METTL3-based epitranscriptomic editing screening identifies functional m 6 A sites in cancers.
Article Snippet: N-methyladenosine (mA) represents the most abundant internal RNA modification and a key regulator of gene expression.. Although individual mA regulators and sites have been linked to cancer, their transcriptome-wide functional landscape remains undefined.. Here we developed an epitranscriptomic screening platform based on targeted mA deposition to identify functional modifications in prostate and lung cancer models.



Similar Products

94
Thermo Fisher gene exp ythdf1 rh02873387 m1
Gene Exp Ythdf1 Rh02873387 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/Gene+Exp%2E+YTHDF1%2C+Rh02873387_m1/pm41965674-131-18--1
Average 94 stars, based on 1 article reviews
gene exp ythdf1 rh02873387 m1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
MedChemExpress ythdf1 antibody
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Ythdf1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pmc13054981-133-5-20
Average 94 stars, based on 1 article reviews
ythdf1 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Proteintech rabbit anti ythdf1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Rabbit Anti Ythdf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pm42533115-85-71-75
Average 96 stars, based on 1 article reviews
rabbit anti ythdf1 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Proteintech ythdf1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Ythdf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/TXNDC5+Antibody/10__1038_slash_s41598___026___68251___w-218-67-69
Average 94 stars, based on 1 article reviews
ythdf1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology ythdf1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Ythdf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Rabbit+pAb/10__1186_slash_s13062___026___00939___5-52-74-75
Average 94 stars, based on 1 article reviews
ythdf1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Obio Technology Corp Ltd lentivirus carrying rat ythdf1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Lentivirus Carrying Rat Ythdf1, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/lentivirus+overexpressing+thbs1/pmc13178915-45-12-18
Average 86 stars, based on 1 article reviews
lentivirus carrying rat ythdf1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
ABclonal Biotechnology rabbit anti ythdf1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Rabbit Anti Ythdf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Rabbit+pAb/pm41825439-840-233-238
Average 94 stars, based on 1 article reviews
rabbit anti ythdf1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Thermo Fisher gene exp ythdf1 hs00697331 m1
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Gene Exp Ythdf1 Hs00697331 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/Gene+Exp%2E+YTHDF1%2C+Hs00697331_m1/pm41965674-132-15-24
Average 94 stars, based on 1 article reviews
gene exp ythdf1 hs00697331 m1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Fortis Life Sciences ythdf1 rabbit
Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
Ythdf1 Rabbit, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pmc12009005-919-0-3
Average 90 stars, based on 1 article reviews
ythdf1 rabbit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant

Journal: Chinese Medicine

Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

doi: 10.1186/s13020-025-01313-9

Figure Lengend Snippet: Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant

Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

Techniques: CCK-8 Assay, Incubation, Protein Array, Negative Control, Positive Control, Binding Assay, Expressing, Immunohistochemistry, Western Blot, Ubiquitin Proteomics, Control

Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)

Journal: Chinese Medicine

Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

doi: 10.1186/s13020-025-01313-9

Figure Lengend Snippet: Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)

Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

Techniques: Transfection, Incubation, CCK-8 Assay, Lactate Dehydrogenase Assay, Western Blot, Colony Assay, Microscopy, Staining, Immunofluorescence, Control

YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)

Journal: Chinese Medicine

Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

doi: 10.1186/s13020-025-01313-9

Figure Lengend Snippet: YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)

Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

Techniques: Western Blot, Expressing, Transfection, Incubation, Binding Assay, Control

Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant

Journal: Chinese Medicine

Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

doi: 10.1186/s13020-025-01313-9

Figure Lengend Snippet: Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant

Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

Techniques: In Vivo, Immunohistochemistry, Staining, Control